Prenatal screening for cystic fibrosis in the United States - Time to re-evaluate implementation policies

Journal of Medical Screening

Volumn 10, Issue 3, 2003, Pages 105-106

  Haddow, James E ^a  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS; DIAGNOSIS, MEASUREMENT AND ANALYSIS; EDITORIAL; FEMALE; HEALTH CARE SYSTEM; HIGH RISK PREGNANCY; HUMAN; LABORATORY DIAGNOSIS; MALE; MUTATION; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRENATAL SCREENING; SCREENING; SCREENING TEST; UNITED STATES;

CYSTIC FIBROSIS; FEMALE; GENETIC SCREENING; HUMANS; PRACTICE GUIDELINES; PREGNANCY; PRENATAL DIAGNOSIS; UNITED STATES;

EID: 1542360055     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1258/096914103769010978     Document Type: Editorial

References (6)

1. Preconception and prenatal carrier screening for cystic fibrosis: clinical and laboratory guidelines. American College of Obstetricians and Gynecologists, American College of Medical Genetics, 2001.
2. Strom CM, Huang D, Buller A, et al. Cystic fibrosis screening using the college panel: platform comparison and lessons learned from the first 20,000 samples. Genet Med 2002;4(4):289-96.
3. Haddow JE, Bradley LA, Palomaki GE, Doherty RA. Issues in implementing prenatal screening for cystic fibrosis: results of a working conference. J Med Screen 1999;6:60-6.
4. Bradley LA, Palomaki GE, Hyman D, et al. Prenatal cystic fibrosis (CF) screening: barriers to demonstrating clinical validity and utility in practice. Abstract presented at the Annual Clinical Genetics Meeting, San Diego, March 13-16, 2003.
5. Wald NJ. Couple screening for cystic fibrosis. Lancet 1991;338:1318-19
6. Wald NJ, Morris JK, Rodeck CH, et al. Cystic fibrosis: selecting the prenatal screening strategy of choice. Prenat Diagn 2003; (in press).